Dow Jones

38 686,32

1,51%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
App Pharmaceuticals (MM) (APPX)
App Pharmaceuticals (MM) (APPX) Actualités

APPX

App Pharmaceuticals (MM) (APPX)

App Pharmaceuticals (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:APPX

1 2 3 4 5 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
13/11/2018	19h13	GlobeNewswire Inc.	APPx Group Holdings, Inc. Signs LOI to Acquire Cimtel (Quebec) Inc.	NASDAQ:APPX	App Pharmaceuticals (MM)
06/11/2018	15h49	GlobeNewswire Inc.	APPx Group Holdings, Inc. Trading on CSE Under Symbol “APPX”	NASDAQ:APPX	App Pharmaceuticals (MM)
10/09/2008	17h17	Edgar (US Regulatory)	App Pharmaceuticals, Inc.-Filing of certain prospectuses and communications for business combination transactions (425)	NASDAQ:APPX	App Pharmaceuticals (MM)
05/09/2008	18h56	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Current report filing (8-K)	NASDAQ:APPX	App Pharmaceuticals (MM)
03/09/2008	22h05	PR Newswire (US)	Mergent, Inc. Announces Changes to the HealthShares(TM) Cancer Index, Composite Index, Dermatology and Wound Care Index, Enablin	NASDAQ:APPX	App Pharmaceuticals (MM)
21/08/2008	12h01	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Information Statement - Merger or Acquisition (definitive) (DEFM14C)	NASDAQ:APPX	App Pharmaceuticals (MM)
18/08/2008	22h59	Business Wire	APP Pharmaceuticals Receives Manufacturing Approval for Three Product Codes of Heparin at Puerto Rico Facility	NASDAQ:APPX	App Pharmaceuticals (MM)
18/08/2008	12h02	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Information Statements (revised) (PRER14C)	NASDAQ:APPX	App Pharmaceuticals (MM)
04/08/2008	22h28	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Quarterly Report (10-Q)	NASDAQ:APPX	App Pharmaceuticals (MM)
01/08/2008	12h15	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Information Statement - Merger or Acquisition (preliminary) (PREM14C)	NASDAQ:APPX	App Pharmaceuticals (MM)
01/08/2008	02h13	Business Wire	APP Pharmaceuticals Reports 2008 Second Quarter Net Revenues of $198 Million, Operating Income of $53 Million	NASDAQ:APPX	App Pharmaceuticals (MM)
24/07/2008	22h35	Business Wire	APP Pharmaceuticals Announces Date for 2008 Second Quarter Financial Results and Investor Conference Call	NASDAQ:APPX	App Pharmaceuticals (MM)
10/07/2008	18h01	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:APPX	App Pharmaceuticals (MM)
08/07/2008	14h30	Marketwired	Market Pulse Breaking News Alert for Tuesday, July 8, 2008: PRRY -- Planet Resource Recovery Receives Significant Purchase Order	NASDAQ:APPX	App Pharmaceuticals (MM)
03/07/2008	14h00	Business Wire	APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, USP	NASDAQ:APPX	App Pharmaceuticals (MM)
30/06/2008	22h53	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Annual Report of Employee Stock Plans (11-K)	NASDAQ:APPX	App Pharmaceuticals (MM)
02/06/2008	16h59	Business Wire	APP Pharmaceuticals Launches Enhanced Labeling for Heparin Sodium Injection, USP	NASDAQ:APPX	App Pharmaceuticals (MM)
15/05/2008	12h55	Business Wire	APP Pharmaceuticals Provides Update on Issues Related to Heparin Crisis and Actions to Ensure Uninterrupted Safe Supply	NASDAQ:APPX	App Pharmaceuticals (MM)
08/05/2008	22h08	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Initial Statement of Beneficial Ownership (3)	NASDAQ:APPX	App Pharmaceuticals (MM)
08/05/2008	14h05	Business Wire	APP Pharmaceuticals Reports 2008 First Quarter Net Revenues of $148 Million, Gross Profit of $70 Million	NASDAQ:APPX	App Pharmaceuticals (MM)
01/05/2008	14h00	Business Wire	APP Pharmaceuticals Announces Date for 2008 First Quarter Financial Results and Investor Conference Call	NASDAQ:APPX	App Pharmaceuticals (MM)
01/05/2008	02h16	Business Wire	APP Pharmaceuticals Names Thomas H. Silberg Chief Executive Officer; Appoints Richard J. Tajak Chief Financial Officer	NASDAQ:APPX	App Pharmaceuticals (MM)
29/04/2008	23h32	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Amended Annual Report (10-K/A)	NASDAQ:APPX	App Pharmaceuticals (MM)
21/04/2008	14h00	Business Wire	APP Pharmaceuticals Receives FDA Approval for Colistimethate For Injection, USP	NASDAQ:APPX	App Pharmaceuticals (MM)
25/03/2008	13h00	Business Wire	APP Pharmaceuticals Launches Cefepime Hydrochloride for Injection	NASDAQ:APPX	App Pharmaceuticals (MM)
17/03/2008	22h30	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Annual Report (10-K)	NASDAQ:APPX	App Pharmaceuticals (MM)
14/03/2008	21h39	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Statement of Ownership (SC 13G)	NASDAQ:APPX	App Pharmaceuticals (MM)
07/03/2008	14h05	Business Wire	APP Pharmaceuticals Reports Record Net Revenues of $647 Million and Gross Profit of $315 Million from Continuing Operations in 2	NASDAQ:APPX	App Pharmaceuticals (MM)
28/02/2008	22h30	Business Wire	APP Pharmaceuticals Announces Date for Fourth Quarter and Full-Year Financial Results and Investor Conference Call	NASDAQ:APPX	App Pharmaceuticals (MM)
28/02/2008	22h17	Edgar (US Regulatory)	App Pharmaceuticals, Inc. - Notification that Annual Report will be submitted late (NT 10-K)	NASDAQ:APPX	App Pharmaceuticals (MM)